Pantoprazole in Cisplatin Nephrotoxicity
Recruiting
Phase 3
Interventional Study
Oncology
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 60 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pantoprazole in Cisplatin Nephrotoxicity
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with head and neck cancer
Exclusion Criteria:
* GFR less than 59.
* DM
* Elevated liver enzymes more than 3 fold.
Contacts